The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Purpose
The regulatory requirements for in-house in-vitro diagnostic medical devices (IVDs) are outlined in the following guidance document.
The guidance is intended to support Australian laboratories that manufacture in-house IVDs to meet regulatory requirements (that commenced on 1 July 2010) to legally supply their in-house IVDs in Australia.
Supply means making the test available and reporting patient/client results of the test.